Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Sell
50
ISRG Quote, Financials, Valuation and Earnings
Last price:
$512.67
Seasonality move
:
7.68%
Day range:
$506.21 - $515.14
52-week range:
$413.82 - $616.00
Dividend yield:
0%
P/E ratio:
75.17x
P/S ratio:
21.35x
P/B ratio:
10.74x
Volume:
1.8M
Avg. volume:
1.8M
1-year change:
17.04%
Market cap:
$183.7B
Revenue:
$8.4B
EPS (TTM):
$6.82
Analysts' Opinion
-
Consensus RatingIntuitive Surgical has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 9 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $581.45, Intuitive Surgical has an estimated upside of 13.42% from its current price of $512.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $350.00 representing 31.73% downside risk from its current price of $512.64.
Fair Value
-
According to the consensus of 24 analysts, Intuitive Surgical has 13.42% upside to fair value with a price target of $581.45 per share.
ISRG vs. S&P 500
-
Over the past 5 trading days, Intuitive Surgical has underperformed the S&P 500 by -2.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Intuitive Surgical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Intuitive Surgical has grown year-over-year revenues for 18 quarters straight. In the most recent quarter Intuitive Surgical reported revenues of $2.3B.
Earnings Growth
-
Intuitive Surgical has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Intuitive Surgical reported earnings per share of $1.92.
Enterprise value:
179.3B
EV / Invested capital:
--
Price / LTM sales:
21.35x
EV / EBIT:
72.97x
EV / Revenue:
20.58x
PEG ratio (5yr expected):
3.25x
EV / Free cash flow:
102.75x
Price / Operating cash flow:
106.63x
Enterprise value / EBITDA:
60.77x
Gross Profit (TTM):
$5.8B
Return On Assets:
14.04%
Net Income Margin (TTM):
28.41%
Return On Equity:
15.82%
Return On Invested Capital:
15.82%
Operating Margin:
25.66%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $6.4B | $7.3B | $8.7B | $1.9B | $2.3B | |
| Gross Profit | $4.3B | $4.9B | $5.8B | $1.2B | $1.5B | |
| Operating Income | $1.6B | $1.8B | $2.5B | $469.4M | $578.1M | |
| EBITDA | $1.9B | $2.3B | $3B | $578.7M | $719M | |
| Diluted EPS | $3.66 | $5.54 | $6.82 | $1.51 | $1.92 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.1B | $5.8B | $6.9B | $7.6B | $7.7B | |
| Total Assets | $11.5B | $13.7B | $13.1B | $15.8B | $19.2B | |
| Current Liabilities | $904.6M | $1.1B | $1.3B | $1.4B | $1.5B | |
| Total Liabilities | $1.4B | $1.5B | $1.8B | $1.8B | $2B | |
| Total Equity | $10.2B | $12.2B | $11.3B | $14B | $17.2B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.6B | $1.7B | $2.7B | $265.4M | $581.6M | |
| Cash From Investing | $2.2B | -$1.1B | -$2.9B | -$128.5M | $213.5M | |
| Cash From Financing | -$2.8B | $46.9M | -$38.2M | -$46.7M | -$235.8M | |
| Free Cash Flow | $1B | $595.8M | $1.7B | $23.5M | $465M | |
ISRG
Sector
Market Cap
$183.7B
$34.5M
Price % of 52-Week High
83.22%
49.05%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
17.04%
-35.15%
Beta (5-Year)
1.642
0.615
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$521.20
200-day SMA
Sell
Level
$530.92
Bollinger Bands (100)
Sell
Level
492.97 - 554.05
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Sell
Level
$524.73
Relative Strength Index (RSI14)
Sell
Level
39.76
ADX Line
Sell
Level
40.47
Williams %R
Buy
Level
-85.5483
50-day SMA
Sell
Level
$536.85
MACD (12, 26)
Buy
Level
140.77
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Sell
Level
-2.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (52.162)
Buy
CA Score
(Annual)
Level (2.0448)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-6.2554)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
Stock Forecast FAQ
In the current month, ISRG has received 14 Buy ratings 9 Hold ratings, and 1 Sell ratings. The ISRG average analyst price target in the past 3 months is $581.45.
-
Where Will Intuitive Surgical Stock Be In 1 Year?
According to analysts, the consensus estimate is that Intuitive Surgical share price will rise to $581.45 per share over the next 12 months.
-
What Do Analysts Say About Intuitive Surgical?
Analysts are divided on their view about Intuitive Surgical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Intuitive Surgical is a Sell and believe this share price will drop from its current level to $350.00.
-
What Is Intuitive Surgical's Price Target?
The price target for Intuitive Surgical over the next 1-year time period is forecast to be $581.45 according to 24 Wall Street analysts, 14 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is ISRG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Intuitive Surgical is a Buy. 14 of 24 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ISRG?
You can purchase shares of Intuitive Surgical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Intuitive Surgical shares.
-
What Is The Intuitive Surgical Share Price Today?
Intuitive Surgical was last trading at $512.67 per share. This represents the most recent stock quote for Intuitive Surgical. Yesterday, Intuitive Surgical closed at $512.64 per share.
-
How To Buy Intuitive Surgical Stock Online?
In order to purchase Intuitive Surgical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is up 21.96% over the past day.
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is up 28.58% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 14.38% over the past day.
